MFG
BSX icon

Magnus Financial Group’s Boston Scientific BSX Stock Holding History

Magnus Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,658
Closed -$211K – 580
2019
Q4 		$211K Buy
+4,658
New +$195K 0.03% 479

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Magnus Financial Group's BSX Position: Q1 2020 in Review

Magnus Financial Group sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 4,658 shares — an estimated $211K sold.

Magnus Financial Group first reported a position in BSX in Q4 2019 and held it in 1 quarter. The position peaked at $211K in Q4 2019. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • Magnus Financial Group reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
  • Magnus Financial Group sold 4,658 Boston Scientific shares in Q1 2020, an estimated $211K.
  • Magnus Financial Group first reported a position in Boston Scientific in Q4 2019 and held it in 1 quarter.
  • Magnus Financial Group's Boston Scientific position peaked at $211K in Q4 2019.
  • 800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Magnus Financial Group's 13F filing for Q1 2020, filed 11 May 2020.